Cargando…

Comment on “Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis”

The present letter to the editor is in response to the research “Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis” by Elshaarawy et al in World J Gastroenterol 2021; 13(5): 424–439. The preoperative assessment of the liver reserve function in hepatocellula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Xiao-Long, Miao, Yan-Dong, Mi, Deng-Hai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790421/ https://www.ncbi.nlm.nih.gov/pubmed/35116123 http://dx.doi.org/10.4251/wjgo.v14.i1.366

Ejemplares similares

Serologic status and safety of inactivated Covid‐19 vaccine for hepatocellular carcinoma patients with cirrhosis after curative liver resection
por: Liu, Fuchen, et al.
Publicado: (2022)

Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis
por: Elshaarawy, Omar, et al.
Publicado: (2021)

Comment on: ‘Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade'
por: Cucchetti, Alessandro, et al.
Publicado: (2016)

Reply to: Comment on: ‘Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade'
por: Johnson, Philip, et al.
Publicado: (2016)

Prognostic role of expression of angiogenesis markers in hepatocellular carcinoma: A bioinformatics analysis
por: Miao, Yan-Dong, et al.
Publicado: (2022)

Platelet lymphocyte ratio and sarcopenia were associated with survival after hepatocellular carcinoma undergoing curative resection
por: Feng, Xuping, et al.
Publicado: (2022)

Prevention of late complications of endoscopic resection of colorectal lesions with a coverage agent: Current status of gastrointestinal endoscopy
por: Miao, Yan-Dong, et al.
Publicado: (2022)

Comment on “Evaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma: An Updated Meta-Analysis”
por: Mo, Han-Yue, et al.
Publicado: (2016)

Response to: Comment on “Evaluation of Antiviral Therapy Performed after Curative Therapy in Patients with HBV-Related Hepatocellular Carcinoma: An Updated Meta-Analysis”
por: Yuan, Peng, et al.
Publicado: (2016)

Is liver transplantation superior to liver resection for hepatocellular carcinoma within Milan criteria?
por: Feng, Qingbo, et al.
Publicado: (2022)

Comment on ‘Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion’
por: Huo, Teh-Ia, et al.
Publicado: (2017)

Reply to ‘Comment on ‘Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion’ ’
por: Waked, Iman, et al.
Publicado: (2017)

Comment on – Observation on the curative effect of horizontal rectus transposition combining recess–resect treatment on monocular elevation deficiency with horizontal strabismus
por: Saluja, Gunjan, et al.
Publicado: (2023)

Comment on “Hepatic-associated Immunoglobulin A Nephropathy in a Child with Liver Cirrhosis and Portal Hypertension”
por: Nasri, Hamid, et al.
Publicado: (2014)

Pelvic Bone Fractures Mimicking Bone Metastases in a Patient with Hepatitis B Virus-Associated Liver Cirrhosis and Hepatocellular Carcinoma
por: Lee, Dong Hyeon, et al.
Publicado: (2012)

Hepatocellular carcinoma in patients with B and C virus hepatitis without cirrhosis
por: Carvalho, Kellyane Santana Dias, et al.
Publicado: (2017)

Effect of Severity of Liver Cirrhosis on Surgical Outcomes of Hepatocellular Carcinoma After Liver Resection and Microwave Coagulation
por: Li, Jiang, et al.
Publicado: (2021)

Salvage Liver Transplantation for Patients with Recurrent Hepatocellular Carcinoma after Curative Resection
por: Wu, LinWei, et al.
Publicado: (2012)

A brief comment on liver resection for hepatocellular carcinoma
por: Xu, Haifeng, et al.
Publicado: (2013)

Comment on “Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma”
por: Qian, Xinye
Publicado: (2023)

How long should physicians follow up with patients after curative treatment for hepatocellular carcinoma?
por: Kim, Bo Hyun
Publicado: (2020)

Histological Severity of Cirrhosis Influences Surgical Outcomes of Hepatocellular Carcinoma After Curative Hepatectomy
por: Liang, Bin-Yong, et al.
Publicado: (2022)

Treatments for recurrent hepatocellular carcinoma: laparoscopic or open repeat liver resection, how to make a decision?
por: Zhang, Chenhao, et al.
Publicado: (2023)

Comment on “Establishing a Porcine Model of Small for Size Syndrome following Liver Resection”
por: Athanasiou, Antonios, et al.
Publicado: (2018)

A comment on ‘A morpho-molecular prognostic model for hepatocellular carcinoma'
por: Halil Sahin, I, et al.
Publicado: (2013)

Response to: “Comment on Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma”
por: Famularo, Simone, et al.
Publicado: (2023)

Radical resection and reconstruction of the sternum for metastasis of hepatocellular carcinoma
por: Yoon, Young Chul, et al.
Publicado: (2020)

Novel preoperative strategies to improve hepatocellular carcinoma resectability
por: Tustumi, Francisco, et al.
Publicado: (2023)

Surgical Resection or Radiofrequency Ablation for Small Hepatocellular Carcinoma
por: Feng, Qingbo, et al.
Publicado: (2022)

Microarray analysis to explore the effect of CXCL12 isoforms in a pancreatic pre-tumor cell model
por: Miao, Yan-Dong, et al.
Publicado: (2021)

Comment on: Acute rejection after liver transplantation is less common, but predicts better prognosis in HBV-related hepatocellular carcinoma patients
por: Akbulut, Sami, et al.
Publicado: (2021)

Sorafenib with or without concurrent transarterial chemoembolization in hepatocellular carcinoma: a cautionary comment of STAH trial
por: Chen, Jia-Hao, et al.
Publicado: (2020)

Response to: Comment on “Establishing a Porcine Model of Small for Size Syndrome following Liver Resection”
por: Golriz, Mohammad, et al.
Publicado: (2018)

Extrahepatic recurrence of hepatocellular carcinoma after curative hepatic resection
por: Byeon, Jangmoo, et al.
Publicado: (2012)

Hepatocellular carcinoma in the absence of liver cirrhosis in a treated hepatitis C virus patient
por: Al Nozha, Omar M., et al.
Publicado: (2009)

A Case of Curative Treatment with Apatinib and Camrelizumab Following Liver Resection for Advanced Hepatocellular Carcinoma
por: Huang, Julu, et al.
Publicado: (2023)

Prevalence of Arterial Hypertension in Cirrhosis of Liver
por: Prabhu P., Rajesh, et al.
Publicado: (2009)

Effects of Antiviral Therapy on the Recurrence of Hepatocellular Carcinoma After Curative Resection or Liver Transplantation
por: Du, Yan, et al.
Publicado: (2012)

Retraction: Salvage Liver Transplantation for Patients with Recurrent Hepatocellular Carcinoma after Curative Resection
Publicado: (2019)

Letter 2 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j01515a0up0a1va1cuhi72k0p3